Exploring the Functional Role of Programmed Death-Ligand 1 (PD-L1) in the Castration-Resistant Prostate Cancer Using...

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Prostate cancer is a leading cause of cancer-related mortality.
• Castration resistance is a primary driver of treatment failure in advanced prostate cancer.

Purpose of the Study:

• To investigate the role of programmed death-ligand 1 (PD-L1) in the development of castration resistance in prostate cancer.
• To elucidate the underlying molecular mechanisms by which PD-L1 influences castration-resistant prostate cancer (CRPC) progression.

Main Methods:

• Analyzed PD-L1 expression in primary prostate cancer and CRPC tissues/cells using western blots and immunohistochemistry.
• Utilized transcriptomic sequencing to explore PD-L1's impact on signaling pathways in CRPC cells.
• Investigated PD-L1's role in tumor progression by assessing proliferation, invasion, and migration after knockdown.

Main Results:

• PD-L1 expression was significantly lower in primary prostate cancer but elevated in CRPC.
• PD-L1 knockdown in CRPC cells suppressed proliferation, invasion, and migration.
• PD-L1 knockdown altered gene expression in pathways related to cell surface interactions, NK cell activity, and sodium channel regulation.
• PD-L1 modulates SCUBE1 expression and influences alternative splicing in CRPC.

Conclusions:

• PD-L1 is upregulated in CRPC and contributes to tumor progression by modulating SCUBE1 expression.
• PD-L1 influences multiple tumor-associated genes and signaling pathways in CRPC cells.
• This study provides insights into PD-L1-mediated signaling and castration resistance mechanisms in prostate cancer.